Key Highlights

  • Xaar plc disclosed on 16 October 2026 that a company closely connected to new chair Daniel Dayan bought 51,000 shares at 147.7p each.
  • The purchase was made on 15 October 2026, just a day after Xaar named Mr Dayan as chair with immediate effect.
  • Mr Dayan has been non-executive chair of Bodycote since 2022 and previously sat on the board of Chemring Group.
  • Outgoing chair Ben Stocks stepped down to take up another role, citing professional focus and concerns over holding too many board seats.
  • Xaar's first-half revenue rose to £29.7m, with adjusted profit before tax of £0.2m marking its first profitable half in several years on an adjusted basis.

Why Xaar Is in Focus on 16 October 2026

Xaar plc (LSE:XAR), the Cambridge-based maker of industrial inkjet printheads, was in the spotlight on Friday 16 October 2026 after a regulatory announcement revealed an early show of confidence from its newly appointed chair. Dayson Enterprises Limited, a company closely associated with Daniel Dayan, bought 51,000 ordinary shares on the London Stock Exchange on 15 October at a price of 147.7p per share.

The disclosure was made under the UK market abuse rules that require directors and their closely associated parties to report dealings. Following the purchase, Mr Dayan holds a beneficial interest in 51,000 shares, which is around 0.06% of Xaar's issued share capital. The roughly £75,000 outlay is modest, but a new chair buying within days of arriving is often read as a vote of confidence.

A Change at the Top of the Board

The share purchase followed a board announcement on Wednesday 14 October, when Xaar plc (LSE:XAR) confirmed that Mr Dayan would become chair with immediate effect, replacing Ben Stocks. Mr Stocks explained that he was leaving to take up an alternative position, pointing to the need for professional focus and a wish to avoid being over-boarded.

Mr Dayan brings considerable industrial governance experience. He has chaired Bodycote, the heat treatment and specialist thermal processing group, since 2022. He also chairs the private businesses Watson Fuels and Aquaspersions Group, and he previously served as a non-executive director at defence technology company Chemring Group.

Business Background: Printheads for Industrial Applications

Xaar designs and manufactures piezoelectric inkjet printheads used in a wide range of industrial settings, from ceramic tiles and glass to packaging, labels, coding and marking, and additive manufacturing. Alongside its core printhead division, the group owns Megnajet, which supplies fluid management systems, and Engineered Print Systems, a US-based system integration business.

The company's strategy centres on high-viscosity jetting, which allows thicker and more functional fluids to be printed. This opens doors in areas such as 3D printing and advanced manufacturing, where Xaar has been working with partners including Chinese manufacturer Flashforge on a desktop 3D printer that management sees as validation of its technology.

Financial Position After the First Half

Xaar's interim results for the six months to the end of June 2026 showed revenue of £29.7m, up from £27.2m a year earlier. The reported operating loss narrowed to £1.1m from £2.6m, and the overall loss reduced to £1.8m from £3.1m. The bottom line was affected by a previously disclosed one-off tax liability of about £1.8m, which is being settled over two years.

On an adjusted basis, which strips out items such as currency effects, restructuring costs and acquisition-related amortisation, Xaar plc (LSE:XAR) reported EBITDA of £1.7m and profit before tax of £0.2m. The core printhead business grew revenue 5.5% to £21m with a gross margin of 37.5% and adjusted operating profit of £2.2m. Megnajet revenue increased 27.3% to £1.4m, while Engineered Print Systems grew 15.9% to £7.3m.

Performance across end markets was mixed. The 3D printing and advanced manufacturing segment grew 28.4%, and wide format graphics and labels rose 8.3%. Coding, marking and direct-to-shape revenue fell 8.5% as some customers deferred orders into the second half, and packaging and textiles dropped sharply as several textile projects remain in development. No interim dividend was declared, as the company continues to prioritise research and development.

Sector and Market Context

Xaar sits within the UK industrial technology space, where demand is closely linked to capital spending by manufacturers. Customer investment in new printing lines can be postponed when economic visibility is poor, and the company has flagged that the Middle East conflict has affected production and energy costs in some customer markets. Higher gold prices have also weighed on jewellery wax printing within its additive manufacturing activity.

Risks to Consider

Xaar has identified risks including geopolitical disruption, supply chain pressures, regulatory change, uncertainty in the US market and the expansion of its operations in Asia. Order timing is another factor, as the deferral of coding and marking orders in the first half shows how lumpy revenue can be. The company remains loss-making on a statutory basis, so investors will be keen to see adjusted profitability translate into reported earnings.

What Investors Are Watching Next

Attention will now turn to whether Xaar plc (LSE:XAR) can deliver the second-half recovery in deferred orders and maintain margin progress in its printhead division. Investors will also be watching for any early strategic signals from Mr Dayan as chair, the commercial launch of partner products using Xaar's high-viscosity technology, and the next trading update ahead of full-year results for 2026.